"CHRISTUS Cancer Treatment Center is based in Shreveport, Louisiana."

During the past decade, Christus Schumpert Cancer Treatment Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christus Schumpert Cancer Treatment Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "NSABP Foundation Inc" with 4 trials sponsored, "Amgen" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christus Schumpert Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Christus Schumpert Cancer Treatment Center" are "Breast Cancer" (7 trials), "Chemotherapy-induced Thrombocytopenia" (2 trials), "Lung Cancer" (2 trials), "Basal Cell Carcinoma" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Christus Schumpert Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "Christus Schumpert Cancer Treatment Center" are "Drug" (21 trials), "Biological" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (5 trials), "Placebo" (4 trials), "cetuximab" (3 trials), "cyclophosphamide" (3 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Christus Schumpert Cancer Treatment Center" are 17 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Christus Schumpert Cancer Treatment Center". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Christus Schumpert Cancer Treatment Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Christus Schumpert Cancer Treatment Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".